DE602004029345D1 - Peptidfragment von lyve-1 und gegen dieses gerichteter antikörper - Google Patents

Peptidfragment von lyve-1 und gegen dieses gerichteter antikörper

Info

Publication number
DE602004029345D1
DE602004029345D1 DE602004029345T DE602004029345T DE602004029345D1 DE 602004029345 D1 DE602004029345 D1 DE 602004029345D1 DE 602004029345 T DE602004029345 T DE 602004029345T DE 602004029345 T DE602004029345 T DE 602004029345T DE 602004029345 D1 DE602004029345 D1 DE 602004029345D1
Authority
DE
Germany
Prior art keywords
peptide fragment
antibody
lyve
amino acid
terminal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004029345T
Other languages
English (en)
Inventor
Kinji Ito
Toshiharu Ishii
Yuri Fukasawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oriental Yeast Co Ltd
Original Assignee
Oriental Yeast Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oriental Yeast Co Ltd filed Critical Oriental Yeast Co Ltd
Publication of DE602004029345D1 publication Critical patent/DE602004029345D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602004029345T 2003-03-14 2004-03-11 Peptidfragment von lyve-1 und gegen dieses gerichteter antikörper Expired - Lifetime DE602004029345D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003070568 2003-03-14
PCT/JP2004/003231 WO2004081035A1 (ja) 2003-03-14 2004-03-11 Lyve-1のペプチドフラグメント及びそれに対する抗体

Publications (1)

Publication Number Publication Date
DE602004029345D1 true DE602004029345D1 (de) 2010-11-11

Family

ID=32984660

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004029345T Expired - Lifetime DE602004029345D1 (de) 2003-03-14 2004-03-11 Peptidfragment von lyve-1 und gegen dieses gerichteter antikörper

Country Status (11)

Country Link
US (2) US7339022B2 (de)
EP (1) EP1614690B1 (de)
JP (1) JP3899362B2 (de)
KR (1) KR20050108390A (de)
CN (1) CN1761679A (de)
AT (1) ATE482973T1 (de)
AU (1) AU2004220209A1 (de)
CA (1) CA2518548C (de)
DE (1) DE602004029345D1 (de)
DK (1) DK1614690T3 (de)
WO (1) WO2004081035A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009125831A1 (ja) * 2008-04-11 2009-10-15 有限会社スリーピー Nk4に対するモノクローナル抗体
GB201901559D0 (en) 2019-02-05 2019-03-27 Syngenta Crop Protection Ag Herbicidal compositions
CN115531558B (zh) * 2022-09-16 2024-07-26 华中科技大学 一种动物肝脏淋巴管系统的标记和三维图谱成像方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231000A (en) * 1987-10-08 1993-07-27 The Mclean Hospital Antibodies to A4 amyloid peptide
WO1998006839A1 (en) * 1996-07-15 1998-02-19 Human Genome Sciences, Inc. Cd44-like protein
US7160985B2 (en) 1997-10-29 2007-01-09 Genentech, Inc. Pro180 polypeptide
US6368794B1 (en) * 1999-01-15 2002-04-09 Incyte Genomics, Inc. Detection of altered expression of genes regulating cell proliferation
US20040018594A1 (en) * 2001-05-03 2004-01-29 Alsobrook John P. Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
JP2005500045A (ja) 2001-07-12 2005-01-06 ルードビッヒ、インスティテュート、フォー、キャンサー、リサーチ リンパ管内皮細胞材料および方法

Also Published As

Publication number Publication date
ATE482973T1 (de) 2010-10-15
JPWO2004081035A1 (ja) 2006-08-24
EP1614690A1 (de) 2006-01-11
US7858751B2 (en) 2010-12-28
US7339022B2 (en) 2008-03-04
EP1614690A4 (de) 2006-07-26
CN1761679A (zh) 2006-04-19
EP1614690B1 (de) 2010-09-29
CA2518548A1 (en) 2004-09-23
KR20050108390A (ko) 2005-11-16
US20060127396A1 (en) 2006-06-15
US20090053202A1 (en) 2009-02-26
DK1614690T3 (da) 2010-12-20
CA2518548C (en) 2011-12-06
WO2004081035A1 (ja) 2004-09-23
AU2004220209A1 (en) 2004-09-23
JP3899362B2 (ja) 2007-03-28

Similar Documents

Publication Publication Date Title
DE112006000677A5 (de) Rekombinante Expression von Proteinen in einer disulfidverbrückten, zweikettigen Form
NO20063026L (no) Antistoffer
CY1118037T1 (el) Αντισωματα εναντι του αβητα και h χρηση τους
DE60232577D1 (de) Oligomerische komplexe von chimären proteinen mit verbessertem immunogenen potential
ES2676023T3 (es) Polipéptidos de IL-22 y proteínas de fusión de IL-22 Fc y métodos de uso
CY1113218T1 (el) Υβριδιο και διμερης εκφραση πρωτεϊνων ναϊσσεριας
PE20090322A1 (es) Fraccion de anticuerpo y anticuerpo antagonista del factor de crecimiento endotelial vascular
EA200700973A1 (ru) Слитый белок, содержащий домен bh3 белка «вh3-только»
ATE159727T1 (de) Kleinste erkennungseinheit eines pem-mucin- ''tandem repeat''-spezifischen monoklonalen antikoerpers
DK2020604T3 (da) Ligand for den G-proteinkoblede receptor FPRL2
WO2002018443A3 (en) A recombinant monoclonal antibody to phosphotyrosine-containing proteins
NZ547629A (en) Antibodies binding to conformationally discriminating epitopes of human IGG Fc receptor IIb and IIb
DE602004029345D1 (de) Peptidfragment von lyve-1 und gegen dieses gerichteter antikörper
DE60118359D1 (de) Humanische pellino-polypeptide
ATE387629T1 (de) Gemeinsame epitope von antigenen aus einer multigen-familie
DK1417222T3 (da) Isolerede polypeptider baseret på den neutraliserende epitop af p17-proteinet fra HIV egnet til vacciner samt neutraliserende anti-p17-antistoffer, der specifikt genkender nævnte neutraliserende epitop
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
ATE466876T1 (de) Immunogene konstrukte
TW200505943A (en) Polypeptide
DK1519951T3 (da) Kationiske ligekædede peptider med antifungale egenskaber
DE60031414D1 (de) Einkettige polypeptide enthaltend n-terminale troponin i fragmente und troponin c
ATE367438T1 (de) Verfahren zur steigerung der expression von menschlichen tnf-rezeptor
JP2005535281A5 (de)
WO2004056316A3 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies
WO2001057215A3 (en) Human g-protein coupled receptor polypeptides and polynucleotides having homology with odorant receptors